JanakiramanSubramanianMDMPH

PubMed

• Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors.
  Abdul Wali Khan, Ben Ponvilawan, Janakiraman Subramanian, Dhruv Bansal> ;Cancers. 2024 Mar 20
• Brief Report: Evaluating the Impact of Perioperative Immune Checkpoint Inhibitor in the Treatment of Patients with Resectable Non-Small Cell Lung Cancer: A Systematic ...
  Sharma, P., Ponvilawan, B., Mahadevia, H., Qasim, H., Bansal, D., Subramanian, J.> ;Clinical Lung Cancer. 2024 Feb 15
• Exceptional synergistic response of PARP inhibitor and immune checkpoint inhibitor in esophageal adenocarcinoma with a germline BRCA2 mutation: a case report.
  Himil Mahadevia, Ben Ponvilawan, Ammar Al-Obaidi, Jennifer Buckley, Janakiraman Subramanian, Dhruv Bansal> ;Therapeutic Advances in Medical Oncology. 2024 Jan 1
• Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer ...
  Elizabeth Marrett, Winghan Jacqueline Kwong, Jipan Xie, Ameur M Manceur, Selvam R Sendhil, Eric Wu, Raluca Ionescu-Ittu, Janakiraman Subramanian> ;Drugs - Real World Outcomes. 2023 Dec 1
• 1 citations
  Outcomes of Immunotherapy Versus Chemotherapy as First-Line Treatment in Advanced NSCLC: A Meta-Analysis of Randomized Clinical Trials.
  Ben Ponvilawan, Parth Sharma, Janakiraman Subramanian, Dhruv Bansal, Mahadevia, H.> ;Journal of Thoracic Oncology. 2023 Sep 1
• 1 citations
  Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?
  Lara Kujtan, Janakiraman Subramanian> ;Translational Lung Cancer Research. 2023 Aug 30
• Molecular Tumor Board Case Series: Targeting KRAS G12C in Lung Cancer.
  Beth Gustafson, Lindsey Douglass, Timothy Pluard, Janakiraman Subramanian> ;Missouri Medicine. 2023 Aug 23
• 1 citations
  Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods.
  Sravani Akula, Sai Charitha Mullaguri, Niklas Max Melton, Archana Katta, Venkata Sai Giridhar Reddy Naga, Shyamson Kandula, Raj Kumar Pedada, Janakiraman Subramanian, ...> ;Cancer Medicine. 2023 Aug 1
• Molecular Tumor Board Case Series: Targeted Treatments For Cancer And Their Toxicities: Amivantamab-Induced Linear IgA Bullous Dermatosis.
  Lindsey Douglass, Beth Gustafson, Janakiraman Subramanian> ;Missouri Medicine. 2023 Apr 24
• Bridging the Gap: Innovative 'Center for Precision Oncology' in Missouri.
  Beth Gustafson, Lindsey Douglass, Timothy Pluard, Janakiraman Subramanian> ;Missouri Medicine. 2023 Mar 2
• Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting.
  Sands, J., Subramanian, J.> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  A review of therapeutic failures in late-stage clinical trials.
  Ritu Jain, Janakiraman Subramanian, Anurag S Rathore> ;Expert Opinion on Pharmacotherapy. 2023 Feb 1
• 1 citations
  Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study.
  Janakiraman Subramanian, Natasha B Leighl, Yoon-La Choi, Teh-Ying Chou, Jeffrey Gregg, Rina Hui, Antonio Marchetti, Mark Silvey, Rebecca Makin, Liane Gillespie-Akar, A...> ;Lung Cancer. 2023 Jan 1
• 2 citations
  Estimated sensitivity profiles of lung cancer specific uncommon BRAF mutants towards experimental and clinically approved kinase inhibitors.
  Sai Charitha Mullaguri, Sravani Akula, Vigneshwar Reddy Ashireddygari, Partha Sarathi Sahoo, V L S Prasad Burra, Ravalika Silveri, Vyshnavika Mupparapu, Meghana Korika...> ;Toxicology and Applied Pharmacology. 2022 Oct 15
• Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
  Ateeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, Sultan Sevgi Turgut, Miles W Grunvald, Tim Rand, Sonal Khare, Jefrey A Borgia, Dana M Hayden, Sam G Pappas, Henry R Govekar...> ;Genome Biology. 2022 Jul 13
• 6 citations
  Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.
  Victor Moreno, Desamparados Roda, Joanna Pikiel, Jose Trigo, Joaquim Bosch-Barrera, Yvette Drew, Rebecca Kristeleit, Sandrine Hiret, David L Bajor, Patricia Cruz, J Th...> ;Clinical Lung Cancer. 2022 Nov 1
• 38 citations
  Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
  Ateeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, Sultan Sevgi Turgut, Miles W Grunvald, Tim Rand, Sonal Khare, Jeffrey A Borgia, Dana M Hayden, Sam G Pappas, Henry R Goveka...> ;Genome Biology. 2022 May 11
• 3 citations
  Squamous cell carcinoma of the lung: improving the detection and management of immune-related adverse events.
  Lara Kujtan, Rama Krishna Kancha, Beth Gustafson, Lindsey Douglass, Christopher Rh Ward, Blake Buzard, Janakiraman Subramanian> ;Expert Review of Anticancer Therapy. 2022 Feb 1
• 17 citations
  NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
  Christian Rolfo, Alexander Drilon, David S. Hong, Caroline E. McCoach, Afshin Dowlati, Jessica J. Lin, Alessandro Russo, Alison M. Schram, Stephen V. Liu, Jorge Nieva,...> ;British Journal of Cancer. 2021 Sep 3
• Challenges in Pathology Specimen Processing in the New Era of Precision Medicine.
  Ossama Tawfik, Janakiraman Subramanian, Samuel Caughron, Pradip Mana, Eric Ewing, Matthew Aboudara, John Borsa, Liudmila Schafer, Timothy Saettele, Sreeni Jonnalagadda> ;Archives of Pathology & Laboratory Medicine. 2021 Aug 23
• 7 citations
  Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung...
  Manuel Dómine Gómez, Tibor Csőszi, Jana Jaal, Iveta Kudaba, Krasimir Nikolov, Davorin Radosavljevic, Jie Xiao, Janet K. Horton, Rajesh K. Malik, Janakiraman Subramanian> ;International Journal of Cancer. 2021 Jul 10
• 8 citations
  Detection of MET exon 14 skipping mutations in non-small cell lung cancer: overview and community perspective.
  Janakiraman Subramanian, Ossama Tawfik> ;Expert Review of Anticancer Therapy. 2021 May 24
• 3 citations
  Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
  Ashiq Masood, Trevor Christ, Samia Asif, Priya Rajakumar, Beth A Gustafson, Leyla Shune, Ameen A. Salahudeen, Drew Nedvad, Suparna Nanua, Agne Paner, Timothy M. Kuzel,...> ;NPJ Genomic Medicine. 2021 Mar 17
• 2 citations
  Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Sa...
  Edward S. Kim, Jonathan K. Kish, Agnieszka Cseh, Barbara Moehring, Wenbo Tang, Elizabeth Terlizzi, Janakiraman Subramanian> ;Clinical Lung Cancer. 2021 Feb 16
• 3 citations
  The Role for Chemotherapy in 80 Years and Older Patients with Metastatic Non-Small Cell Lung Cancer: A National Cancer Database Analysis
  Zaheer Ahmed, Kevin Kennedy, Janakiraman Subramanian> ;Lung Cancer. 2021 Feb 16
• Join now to see all